Member Info for Rocket79

Agree this is massively oversold. Bug buys now coning in, ahead of news flow. Anything under 100p is a gift imo dyor

I'm expecting these to steadily rise. News on multiple fronts in coming weeks.

Great find.News must be very close here. June was the expected release date... insiders buying in ahead of news???

Some major buying going on here. The company looks well run and non exec director loading up on share shows confidence. News on multiple front due. Buy

It was a Uncrossing Trade so no significance. It was not a sell or a buy. Dyor

Non of this great news is priced in. These will rise above 150p in coming sessions imo

Is the price being held down due to imminent placing? Funds are low? If there is a placing it will be at big discount to current sp.

This share price is ridiculously low. It won't last long. Load up while you can. Weak holders almost out. Plenty of news flow this year. Strong Buy

Follow the smart money. Directors have bought in Big and already hold a substantial amount of shares. Massive vote of confidence. Strong Buy

Oncology readouts June, September this year. With Asthma in Q3.

A new tax year another opportunity to put 20k into 4d Pharma. Very excited with all the news expected 2021.

Fantastic opportunity here for those genuine holders. Plenty of news this year for a rerate of the share price imo.

You have already shown us that you are not very knowledgeable and don't do your own research. Dyor, added to my filter list as you are really clueless when it comes to investing.

Truly remarkable. The market certainly is undervaluing 4d..

In August, we announced comprehensive clinical benefit data from the 12 patients enrolled into Part A of the trial. Five patients (42%) demonstrated clinical benefit (defined as a complete response, partial response or stable disease for six months or longer) on treatment with MRx0518 and Keytruda(R), including three patients achieving partial responses, an objective response rate of 25%. To the best of our knowledge, we have delivered the FIRST EVER PROOF-OF-CONCEPT DATA in the TREATMENT of CANCER using LBPs.

Strong Buy

Sang talking to himself as he is also the poster Fly. What a fool you are.

Sang = fool

RNS
Steven Oliveira increasing stake to 12.14%

Now why would such a renowned investor increase his stake in 4d? Follow the smart money Buy

Good post wigscoff88. 4d Pharma valuation will come good. Patience required. 4d Pharma is in an exciting and expanding area with partners such as Merck and Pfizer. Good luck holders.

www.valuethemarkets.com/2021/03/23/4d-pharma-hits-transformational-milestone-as-merger-brings-cash-and-dual-listing/

Buy and hold 4d is going alot higher. Let's all make money.